Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Adrenal gland

Congenital adrenal hyperplasia: new treatment guidelines

Congenital adrenal hyperplasia is one of the most prevalent genetic endocrine diseases. A new guideline from the Endocrine Society offers expert opinion and evidence-based recommendations on the diagnosis and management of this challenging condition.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Speiser, P. W. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 4133–4160 (2010).

    Article  CAS  Google Scholar 

  2. Riepe, F. G. & Sippell, W. G. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Rev. Endocr. Metab. Disord. 8, 349–363 (2007).

    Article  CAS  Google Scholar 

  3. Fernández-Balsells, M. M. et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia due to 21 hydroxylase (CYP21A2) deficiency: A systematic review and meta-analyses. Clin. Endocrinol. (Oxf.) doi: 10.1111/j.1365-2265.2010.03826.x.

  4. Muthusamy, K. et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 95, 4161–4172 (2010).

    Article  CAS  Google Scholar 

  5. Rivkees, S. A. Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the “growth toxic” glucocorticoid. Int. J. Pediatr. Endocrinol. 2010, 569680 (2010).

  6. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J. Clin. Endocrinol. Metab. 87, 4048–4053 (2002).

  7. [No authors listed] Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics. Pediatrics 106, 1511–1518 (2000).

  8. New, M. I. et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J. Clin. Endocrinol. Metab. 86, 5651–5657 (2001).

    Article  CAS  Google Scholar 

  9. Arlt, W. et al. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2010-0917.

Download references

Acknowledgements

F. G. Riepe is supported in part by the project EuroDSD in the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement 201444.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riepe, F. Congenital adrenal hyperplasia: new treatment guidelines. Nat Rev Endocrinol 7, 6–8 (2011). https://doi.org/10.1038/nrendo.2010.197

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2010.197

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing